Myocardial, Valvular, and Vascular Structural and Functional Properties in Acromegaly.
Attila NemesÁrpád KormányosNóra AmbrusCsaba LengyelZsuzsanna ValkuszPublished in: Journal of clinical medicine (2023)
Acromegaly is an uncommon systematic endocrine disease caused by the hypersecretion of human growth hormone and, consequently, of insulin-like growth factor-1 during adulthood. Acromegaly could cause a typical cardiomyopathy characterized by left ventricular hypertrophy associated with diastolic dysfunction, which later could progress to systolic dysfunction. Moreover, some valvular and vascular abnormalities are also associated with acromegaly. This present review aims to summarize available information regarding acromegaly-associated abnormalities in myocardial, valvular, and vascular structural and functional properties and their relationship to disease activity and treatment options.
Keyphrases
- growth hormone
- left ventricular
- disease activity
- atrial fibrillation
- heart failure
- rheumatoid arthritis
- hypertrophic cardiomyopathy
- systemic lupus erythematosus
- cardiac resynchronization therapy
- acute myocardial infarction
- blood pressure
- aortic stenosis
- left atrial
- endothelial cells
- mitral valve
- aortic valve
- rheumatoid arthritis patients
- ankylosing spondylitis
- oral anticoagulants
- juvenile idiopathic arthritis
- healthcare
- depressive symptoms
- acute coronary syndrome
- percutaneous coronary intervention
- pluripotent stem cells
- early life